Massachusetts General Hospital’s talented and dedicated researchers are working to push the boundaries of science and medicine every day. Continue reading to hear from a few individuals who have recently received awards or honors for their achievements: Erin C. Dunn, ScD, MPH, of the Center for Genomic Medicine and the Department of Psychiatry, has received […]
You have probably seen a futuristic-looking hunk of metal clutched in the hands of a passing stranger, followed by seemingly endless, thick clouds of sweet-smelling smoke. E-cigarette. E cig. Mod. Tank system. Vape pen. E-hookah. All of them are names for cigarettes’ flavored and more modern new competitor that has become incredibly popular with adolescents. […]
Industry-academia collaborations are key for the development of new medical technologies and drugs that can provide better care for our patients. The Mass General Research Institute recognizes the importance of these relationships in moving healthcare forward and has increased its efforts to work collaboratively with industry. This has led to an 18% increase in industry-sponsored research […]
Can a light-based treatment called photobiomodulation help to treat degenerative brain diseases?
The REVIVE clinical trial team is seeking feedback from the public on their study testing the use of RESQFOAM in severely injured trauma patients.
Researchers at the Ragon Institute of Massachusetts General Hospital, MIT and Harvard recently published an editorial in Science Immunology detailing their efforts to combine basic science and social good to reduce the high rate of HIV infection in young South African women while simultaneously empowering them. Here is a brief summary.
Folate levels have, once again, become an area of interest for a Massachusetts General Hospital -based research team after finding that increased in utero folic acid exposure is associated with changes in brain development later in life that could reduce the risk of psychosis and schizophrenia.